183 related articles for article (PubMed ID: 27067323)
41. Failure of oily chloramphenicol depot injection to treat plague in a murine model.
Rahalison L; Guiyoule A; Bonacorsi SP; Slacanin I; Chanteau S; Carniel E
J Antimicrob Chemother; 2000 Apr; 45(4):541-5. PubMed ID: 10747836
[TBL] [Abstract][Full Text] [Related]
42. Finding a sugary foothold: how antibiotics pave the way for enteric pathogens.
Stecher B
Cell Host Microbe; 2013 Sep; 14(3):225-7. PubMed ID: 24034607
[TBL] [Abstract][Full Text] [Related]
43. An Oral Fluorouracil Prodrug, Capecitabine, Mitigates a Gram-Positive Systemic Infection in Mice.
McLeod JR; Harvey PA; Detweiler CS
Microbiol Spectr; 2021 Sep; 9(1):e0027521. PubMed ID: 34190602
[TBL] [Abstract][Full Text] [Related]
44. Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.
Hoang KV; Borteh HM; Rajaram MV; Peine KJ; Curry H; Collier MA; Homsy ML; Bachelder EM; Gunn JS; Schlesinger LS; Ainslie KM
Int J Pharm; 2014 Dec; 477(1-2):334-43. PubMed ID: 25447826
[TBL] [Abstract][Full Text] [Related]
45. An antibiotic-altered microbiota provides fuel for the enteric foe.
Stiemsma LT; Turvey SE; Finlay BB
Cell Res; 2014 Jan; 24(1):5-6. PubMed ID: 24165893
[TBL] [Abstract][Full Text] [Related]
46. The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes.
Jamilloux Y; Magnotti F; Belot A; Henry T
Pathog Dis; 2018 Apr; 76(3):. PubMed ID: 29718184
[TBL] [Abstract][Full Text] [Related]
47. Repurposing FDA-approved drugs for anti-aging therapies.
Snell TW; Johnston RK; Srinivasan B; Zhou H; Gao M; Skolnick J
Biogerontology; 2016 Nov; 17(5-6):907-920. PubMed ID: 27484416
[TBL] [Abstract][Full Text] [Related]
48. Successful Treatment of Human Plague with Oral Ciprofloxacin.
Apangu T; Griffith K; Abaru J; Candini G; Apio H; Okoth F; Okello R; Kaggwa J; Acayo S; Ezama G; Yockey B; Sexton C; Schriefer M; Mbidde EK; Mead P
Emerg Infect Dis; 2017 Mar; 23(3):553-5. PubMed ID: 28125398
[TBL] [Abstract][Full Text] [Related]
49. Experimental diarrhea: salmonella enterocolitis inthe rat.
Maenza RM; Powell DW; Plotkin GR; Formal SB; Jervis HR; Sprinz H
J Infect Dis; 1970 May; 121(5):475-85. PubMed ID: 4911807
[No Abstract] [Full Text] [Related]
50. How enteric pathogens know they hit the sweet spot.
Alvarado I; Abel-Santos E
Future Microbiol; 2014; 9(1):13-6. PubMed ID: 24328376
[TBL] [Abstract][Full Text] [Related]
51. Repurposing of FDA approved drugs and their validation against potential drug targets for
Kesharwani A; Chaurasia DK; Katara P
J Biomol Struct Dyn; 2022 Sep; 40(14):6255-6271. PubMed ID: 33525976
[No Abstract] [Full Text] [Related]
52. Comprehensive Host Cell-Based Screening Assays for Identification of Anti-Virulence Drugs Targeting
von Ambüren J; Schreiber F; Fischer J; Winter S; van Gumpel E; Simonis A; Rybniker J
Microorganisms; 2020 Jul; 8(8):. PubMed ID: 32707871
[TBL] [Abstract][Full Text] [Related]
53. Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors.
Cho Y; Vermeire JJ; Merkel JS; Leng L; Du X; Bucala R; Cappello M; Lolis E
Chem Biol; 2011 Sep; 18(9):1089-101. PubMed ID: 21944748
[TBL] [Abstract][Full Text] [Related]
54. Polypharmacological drug actions of recently FDA approved antibiotics.
Wetzel C; Lonneman M; Wu C
Eur J Med Chem; 2021 Jan; 209():112931. PubMed ID: 33127170
[TBL] [Abstract][Full Text] [Related]
55. Reducing mortality in Salmonella enterica serovar Typhimurium-infected mice with a tripeptidic serum fraction.
Parker TA; Willeford KO; Parker S; Buddington K
Antimicrob Agents Chemother; 2002 Jun; 46(6):1971-3. PubMed ID: 12019117
[TBL] [Abstract][Full Text] [Related]
56. Attachment of Yersinia pestis to human respiratory cell lines is inhibited by certain oligosaccharides.
Thomas R; Brooks T
J Med Microbiol; 2006 Mar; 55(Pt 3):309-315. PubMed ID: 16476795
[TBL] [Abstract][Full Text] [Related]
57. Large-scale bioactivity analysis of the small-molecule assayed proteome.
Backman TW; Evans DS; Girke T
PLoS One; 2017; 12(2):e0171413. PubMed ID: 28178331
[TBL] [Abstract][Full Text] [Related]
58. Nifuratel reduces
Xie T; Liu G; Ma J; Wang Y; Gao R; Geng S; Jiao X; Barrow P
Microbiol Spectr; 2023 Sep; 11(5):e0514722. PubMed ID: 37732770
[No Abstract] [Full Text] [Related]
59. Susceptibility of Virulent
Russo R; Kolesnikova I; Kim T; Gupta S; Pericleous A; Kadouri DE; Connell ND
Microorganisms; 2018 Dec; 7(1):. PubMed ID: 30577606
[TBL] [Abstract][Full Text] [Related]
60. Integrating chemical and genetic silencing strategies to identify host kinase-phosphatase inhibitor networks that control bacterial infection.
Albers HM; Kuijl C; Bakker J; Hendrickx L; Wekker S; Farhou N; Liu N; Blasco-Moreno B; Scanu T; den Hertog J; Celie P; Ovaa H; Neefjes J
ACS Chem Biol; 2014 Feb; 9(2):414-22. PubMed ID: 24274083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
